Dr. Barry Dworkin

Health Canada approves Pfizer’s new COVID-19 vaccine targeting Omicron XBB.1.5 subvariant

Medical Mythbusting Commentary for September 29, 2023

Source:
Health Canada approves Pfizer’s new COVID-19 vaccine targeting Omicron XBB.1.5 subvariant

Related posts:

  1. Hope? Sure, but tone down the touting of experimental Pfizer drug to treat early Covid that hasn’t completed its 60-person phase 1 trial. And Miami private school ban on Covid-19-vaccinated teachers enters the pantheon of the Bizarro World.
  2. What should your #seconddose of #covidvaccine be if 1st was AZ? Factors include wait-time/availability, Delta variant prevalence, occupational risks, and study evidence. Answer seems to leaning to Pfizer or Moderna as 2nd dose of choice.
  3. Pfizer to provide COVID vaccine trial data covering 5 to 11 year-olds to Health Canada for review and authorization. Company press releases are one thing but proper evaluation and scrutiny of the evidence is required.
  4. Pfizer applies to FDA for approval of three-dose pediatric COVID-19 vaccine for children under five years of age.